Skip to content
GraphTheory.in

Mukesh C. Sharma

School of Pharmacy,Devi Ahilya VishwavidyalayaIN
ORCID0000-0003-0222-5273
h-index
24

via OpenAlex

Citations
2,637

via OpenAlex

Publications
302

About

Mukesh C. Sharma is an academic researcher at the School of Pharmacy, Devi Ahilya Vishwavidyalaya. He has authored 53 publications spanning from 2006 to 2015. Sharma's research focus lies in the application of molecular modeling and QSAR approaches to discover new biologically active compounds. His work covers a range of therapeutic areas, including antihypertensive agents, antibacterial agents, anti-malarial activity, and potent inhibitors.

Research areas

  • Chemistry
  • Medicine
  • Biology
  • Stereochemistry
  • Organic chemistry

Publications (302)

Sorted by most cited.

  1. Indian kala-azar caused by Leishmania tropica

    1995

    View DOI
    128 cites
  2. Herbage, oil yield and oil quality of patchouli [Pogostemon cablin (Blanco) Benth.] influenced by irrigation, organic mulch and nitrogen application in semi-arid tropical climate

    2002

    View DOI
    86 cites
  3. Graphene-based hybrid nanoparticle of doxorubicin for cancer chemotherapy

    International Journal of Nanomedicine1970journal article

    View DOI
    60 cites
  4. 3D QSAR kNN-MFA studies on 6-substituted benzimidazoles derivatives as Nonpeptide Angiotensin II Receptor Antagonists: A rational approach to antihypertensive agents

    2011

    View DOI
    52 cites
  5. Synthesis and QSAR studies on 5-[2-(2-methylprop1-enyl)-1H benzimidazol-1yl]-4,6-diphenyl-pyrimidin-2-(5H)-thione derivatives as antibacterial agents

    2006

    View DOI
    48 cites
  6. Thiolated-Chitosan: A Novel Mucoadhesive Polymer for Better-Targeted Drug Delivery

    2019

    View DOI
    37 cites
  7. Importance of toxicity testing in drug discovery and research

    2022

    View DOI
    36 cites
  8. 36 cites
  9. Validated RP-HPLC method for determining the levels of bromhexine HCl, chlorpheniramine maleate, dextromethorphan HBr and guaiphenesin in their pharmaceutical dosage forms

    2015

    View DOI
    34 cites
  10. Insight into the structural requirement of substituted quinazolinone biphenyl acylsulfonamides derivatives as Angiotensin II AT1 receptor antagonist: 2D and 3D QSAR approach

    2011

    View DOI
    31 cites
  11. 29 cites
  12. Forensic Study of Indian Toxicological Plants as Botanical Weapon (BW): A Review

    2011

    View DOI
    26 cites
  13. Pharmacophore and QSAR modeling of some structurally diverse azaaurones derivatives as anti-malarial activity

    2013

    View DOI
    25 cites
  14. Three-dimensional quantitative structure–activity relationship (3D-QSAR) analysis and molecular docking-based combined in silico rational approach to design potent and novel TRPV1 antagonists

    2012

    View DOI
    25 cites
  15. A comprehensive structure–activity analysis 2,3,5-trisubstituted 4,5-dihydro-4-oxo-3H-imidazo [4,5-c] pyridine derivatives as angiotensin II receptor antagonists: using 2D- and 3D-QSAR approach

    2012

    View DOI
    25 cites
  16. WITHDRAWN: An approach to design antihypertensive agents by 2D QSAR studies on series of substituted benzimidazoles derivatives as angiotensin II receptor antagonists

    2011

    View DOI
    25 cites
  17. In silico methods for the prediction of drug toxicity

    2022

    View DOI
    24 cites
  18. Pharmacophore modeling and atom-based 3D-QSAR studies on amino derivatives of indole as potent isoprenylcysteine carboxyl methyltransferase (Icmt) inhibitors

    2014

    View DOI
    24 cites
  19. Honey As Complementary Medicine: A Review

    2012

    24 cites
  20. Insight into the structural requirement of aryltriazolinone derivatives as angiotensin II AT1 receptor: 2D and 3D-QSAR k-Nearest Neighbor Molecular Field Analysis approach

    2011

    View DOI
    24 cites
  21. WITHDRAWN: QSAR analysis and 3D QSAR kNN-MFA approach on a series of substituted quinolines derivatives as angiotensin II receptor antagonists

    2011

    View DOI
    24 cites
  22. Development and Validation of TLC-Densitometry Method for Simultaneous Quantification of Montelukast Sodium and Levocetirizine Dihydrochloride Pharmaceutical Solid dosage form

    2010

    24 cites
  23. Influence of micronutrient imbalance on growth and artemisinin content in artemisia annua.

    1990

    24 cites
  24. Screening of genetic resources of the medicinal-vegetable plant<i>Centella asiatica</i>for herb and asiaticoside yields under shaded and full sunlight conditions

    2000

    View DOI
    23 cites
  25. Big Data Analysis of Traditional Knowledge-based Ayurveda Medicine

    2018

    View DOI
    22 cites
  26. Molecular Modeling Studies of Thiophenyl C-Aryl Glucoside SGLT2 Inhibitors as Potential Antidiabetic Agents

    2014

    View DOI
    22 cites
  27. Relationship of Adipocyte Size with Adiposity and Metabolic Risk Factors in Asian Indians

    2014

    View DOI
    22 cites
  28. WITHDRAWN: Predicting substituted 2-butylbenzimidazoles derivatives as angiotensin II receptor antagonists: 3D-QSAR and pharmacophore modeling

    2011

    View DOI
    22 cites
  29. WITHDRAWN: QSAR studies on substituted benzimidazoles as angiotensin II receptor antagonists: kNN-MFA approach

    2011

    View DOI
    22 cites
  30. 21 cites
  31. Trifluorophenyl-based inhibitors of dipeptidyl peptidase-IV as antidiabetic agents: 3D-QSAR COMFA, CoMSIA methodologies

    2017

    View DOI
    21 cites
  32. 2D Qsar Study of 7-Methyljuglone Derivatives: An Approach to Design Anti Tubercular Agents

    2011

    View DOI
    21 cites
  33. New cytotoxic callipeltins from the Solomon Island marine sponge Asteropus sp.

    2016

    View DOI
    20 cites
  34. Comparative QSAR and pharmacophore modeling of substituted 2-[2′-(dimethylamino) ethyl]-1, 2-dihydro-3H-dibenz[de,h]isoquinoline-1,3-diones derivatives as anti-tumor activity

    2013

    View DOI
    20 cites
  35. WITHDRAWN: Two dimensional and k-nearest neighbor molecular field analysis approach on substituted Triazolone derivatives: An insight into the structural requirement for the angiotensin II receptor antagonist

    2011

    View DOI
    20 cites
  36. WITHDRAWN: QSAR analysis of imidazo[4,5-b]pyridine substituted α-Phenoxyphenylacetic acids as angiotensin II AT1 receptor antagonists

    2011

    View DOI
    20 cites
  37. A click chemistry strategy to synthesize geraniol-coupled 1,4-disubstituted 1,2,3-triazoles and exploration of their microbicidal and antioxidant potential with molecular docking profile

    2015

    View DOI
    19 cites
  38. WITHDRAWN: QSAR studies of a series of angiotensin II receptor substituted benzimidazole bearing acidic heterocycles derivatives

    2011

    View DOI
    19 cites
  39. Functionalized Carbon Nanotubes for Protein, Peptide, and Gene Delivery

    2019

    View DOI
    18 cites
  40. WOUND HEALING ACTIVITY AND FORMULATION OF ETHER-BENZENE- 95% ETHANOL EXTRACT OF HERBAL DRUG MADHUCA LONGIFOLIA LEAVES IN ALBINO RATS

    2010

    18 cites
  41. Response of lemongrass ( Cymbopogon flexuosus ) under different levels of irrigation on deep sandy soils

    2000

    View DOI
    18 cites
  42. Methods and models for in vitro toxicity

    2022

    View DOI
    17 cites
  43. Comprehensive two and three-dimensional QSAR studies of 3-substituted 6-butyl-1,2dihydropyridin-2-ones derivatives as angiotensin II receptor antagonists

    2012

    View DOI
    17 cites
  44. WITHDRAWN: Quantitative structure–activity analysis studies on triazolinone aryl and nonaryl substituents as angiotensin II receptor antagonists

    2012

    View DOI
    17 cites
  45. Benzimidazoles derivatives with (2-{6-Chloro-5-nitro-1-[2-(1H-tetrazol-5-yl) biphenyl-4-ylmethyl] 1H-benzoimidazol-2-yl}-phenyl)-(substituted-benzylidene)-amine with potential angiotensin II receptor antagonists as antihypertensive activity.

    2010

    View DOI
    17 cites
  46. Phytochemical, Preliminary Pharmacognostical and Antimicrobial Evaluation of Combined Crude Aqueous Extract

    2010

    17 cites
  47. New Synthetic Approach to Memantine Hydrochloride starting from 1,3-Dimethyl-adamantane

    2007

    View DOI
    17 cites
  48. Comprehensive structure–activity relationship analysis of substituted 5-(biphenyl-4-ylmethyl) pyrazoles derivatives as AT1 selective angiotensin II receptor antagonists: 2D and kNNMFA QSAR approach

    2012

    View DOI
    16 cites
  49. WITHDRAWN: Structural insight for (6-oxo-3-pyridazinyl)-benzimidazoles derivatives as angiotensin II receptor antagonists: QSAR, pharmacophore identification and kNNMFA approach

    2012

    View DOI
    16 cites
  50. WITHDRAWN: A comprehensive structure–activity analysis of 5-Carboxyl Imidazolyl biphenyl Sulfonylureas derivatives angiotensin AT1 receptor antagonists: 2D- and 3D-QSAR approach

    2012

    View DOI
    16 cites
  51. QSAR, SYNTHESIS AND BIOLOGICAL ACTIVITY STUDIES OF SOME THIAZOLIDINONES DERIVATIVES

    2009

    16 cites
  52. Herb Yield and Bacoside-A Content of Field-Grown<i>Bacopa monnieri</i>Accessions

    2002

    View DOI
    16 cites
  53. 2,4-Dihydropyrano[2,3-c]pyrazole: Discovery of new lead as through pharmacophore modelling, atom-based 3D-QSAR, virtual screening and docking strategies for improved anti-HIV-1 chemotherapy

    2015

    View DOI
    15 cites
  54. Molecular modeling and pharmacophore approach for structural requirements of some 2-substituted-1-naphthols derivatives as potent 5-lipoxygenase inhibitors

    2013

    View DOI
    15 cites
  55. WITHDRAWN: QSAR analyses and pharmacophore studies of tetrazole and sulfonamide analogs of imidazo[4,5-b]pyridine using simulated annealing based feature selection

    2012

    View DOI
    15 cites
  56. WITHDRAWN: Comprehensive structure–activity relationship analysis of isoxazolinyl and isoxazolidinyl substituted quinazolinone derivatives as angiotensin II receptor antagonists

    2012

    View DOI
    15 cites
  57. WITHDRAWN: Structural insights for 5-β-Ketosulfoxide Imidazolyl Biphenyl Sulfonylureas derivatives as angiotensin II AT1 receptor antagonists using kNN-MFA with genetic algorithm

    2012

    View DOI
    15 cites
  58. Syntheses, X-ray crystal structure and magnetic studies of a new dinuclear CuII complex, [Cu2(μ-Cl)2L2Cl2]·2CH3CN, L: N,N,N′,N′-tetraisopropylpyridine-2,6-dicarboxamide

    2010

    View DOI
    15 cites
  59. Guiding Factors and Surface Modification Strategies for Biomaterials in Pharmaceutical Product Development

    2019

    View DOI
    14 cites
  60. Synthesis and biological evaluation of some new benzimidazoles derivatives 4'-{5-amino-2-[2-substituted-phenylamino)-phenyl-methyl]-benzimidazol-1 ylmethyl}-biphenyl-2-carboxylic acid: Nonpeptide angiotensin II receptor antagonists.

    2010

    View DOI
    14 cites
  61. Phytochemical and Pharmacological Screening of Combined Mimosa pudica Linn and Tridax procumbens for In vitro Antimicrobial Activity

    2010

    14 cites
  62. INFLUENCE OF TOPOGRAPHICAL AND EDAPHIC FACTORS ON ROSE. II. FLOWERING QUALITY AND QUANTITY

    2002

    View DOI
    14 cites
  63. Drug–drug interactions and their implications on the pharmacokinetics of the drugs

    2022

    View DOI
    13 cites
  64. QSAR studies of novel 1-(4-methoxyphenethyl)-1H-benzimidazole-5-carboxylic acid derivatives and their precursors as antileukaemic agents

    2015

    View DOI
    13 cites
  65. 12 cites
  66. VALIDATED SIMULTANEOUS SPECTROPHOTOMETRIC ESTIMATION OF PAROXETINE HCL BULK AND TABLET DOSAGE FORM USING FERRIC CHLORIDE

    2010

    12 cites
  67. 2D-QSAR STUDIES OF SOME 1, 3, 4-THIDIAZOLE-2YL AZETIDINE 2-ONE AS ANTIMICROBIAL ACTIVITY

    2009

    12 cites
  68. Molecular modeling studies of substituted 3,4-dihydroxychalcone derivatives as 5-lipoxygenase and cyclooxygenase inhibitors

    2013

    View DOI
    11 cites
  69. WITHDRAWN: QSAR and pharmacophore modeling of some benzimidazole derivatives as Protein Kinase CK2 Inhibitors

    2013

    View DOI
    11 cites
  70. WITHDRAWN: Study of physicochemical properties-inducible nitric oxide synthase relationship of substituted quinazolinamines analogs: Pharmacophore identification and QSAR studies

    2013

    View DOI
    10 cites
  71. Phytochemical screening of methanolic extract and antibacterial activity of Eclipta alba and Morinda citrifolia L.

    2010

    10 cites
  72. Antifungal activity of &lt;i&gt; Millingtonia hortensis&lt;/i&gt;

    2007

    View DOI
    10 cites
  73. Toxicity and toxicokinetic considerations in product development and drug research

    2022

    View DOI
    9 cites
  74. Excipient toxicity and safety

    2022

    View DOI
    9 cites
  75. 2D QSAR studies of the inhibitory activity of a series of substituted purine derivatives against c-Src tyrosine kinase

    2015

    View DOI
    9 cites
  76. Molecular modelling studies for the discovery of new substituted pyridines derivatives with angiotensin II AT1 receptor antagonists

    2014

    View DOI
    9 cites
  77. Comparative QSAR and pharmacophore analysis for a series of 2,4-dihydro-3H-1,2,4-triazol-3-ones derivatives as angiotensin II AT1 receptor antagonists

    2013

    View DOI
    9 cites
  78. QSAR and pharmacophore approach on substituted imidazole derivatives as angiotensin II receptor antagonists

    2013

    View DOI
    9 cites
  79. Densitometric Method for the Quantitative Determination of Esomeprazole and Domperidone in Dosage Forms

    2011

    9 cites
  80. STUDY OF STRESSED DEGRADATION BEHAVIOR OF PIOGLITAZONE HYDROCHLORIDE IN BULK AND PHARMACEUTICAL FORMULATION BY HPLC ASSAY METHOD

    2010

    9 cites
  81. 3D- QSAR STUDIES, BIOLOGICAL EVALUATION STUDIES ON SOME SUBSTITUTED 3-CHLORO-1-(5-(5-CHLORO-2-PHENYL-BENZIMIDAZOLE-1- YLMETHYL)-(1, 3, 4) THIADIAZOLE-2-YL)-AZETIDIN-2-ONE AS POTENTIAL ANTIMICROBIAL ACTIVITY

    2009

    9 cites
  82. Two dimensional- quantitative Structure activity relationships -2, 3 diarylthiophenes as selective COX-1-2 inhibitors

    2009

    View DOI
    9 cites
  83. Toxicokinetic and toxicodynamic considerations in drug research

    2022

    View DOI
    8 cites
  84. Pharmaceutical excipients: special focus on adverse interactions

    2022

    View DOI
    8 cites
  85. Factors influencing drug toxicity

    2022

    View DOI
    8 cites
  86. Structural requirements of<i>N</i>-aryl-oxazolidinone-5-carboxamide derivatives for anti-HIV protease activity using molecular modelling techniques

    2013

    View DOI
    8 cites
  87. Discovery of new lead pyrimidines derivatives as potential cannabinoid CB1 receptor antagonistic through molecular modeling and pharmacophore approach

    2013

    View DOI
    8 cites
  88. Predicting Alkylbenzimidazole Derivatives as Angiotensin II Receptor Antagonists: 3d Qsar by kNN-MFA Approach

    2011

    8 cites
  89. Occurrence of Bacterial Flora in Oral Infections of Diabetic and Non- Diabetic Patients

    2011

    8 cites
  90. Preliminary phytochemical and antimicrobial investigations of the aqueous extract of Ixora coccinea Linn and Commelina benghalensis L. on gram-positive and gram-negative microorganisms.

    2010

    8 cites
  91. UV-DENSITOMETRIC DETERMINATION OF SPARFLOXACIN AND ITS APPLICATION TO THE ASSAY IN PHARMACEUTICAL DOSAGE FORMS

    2010

    8 cites
  92. QSAR studies on pyrazole-4-carboxamide derivatives as Aurora A kinase inhibitors

    2015

    View DOI
    7 cites
  93. Comparative Pharmacophore Modeling and QSAR Studies for Structural Requirements of some Substituted 2-Aminopyridine Derivatives as Inhibitors of Nitric Oxide Synthases

    2015

    View DOI
    7 cites
  94. Syntheses and structures of cobalt(II), nickel(II), and copper(II) complexes with <i>N</i>,<i>N</i>,<i>N</i>′,<i>N</i>′-tetraalkylpyridine-2,6-dicarboxamides (O-daap) containing nitrate as the counter ion

    2011

    View DOI
    7 cites
  95. NOVEL METHOD FOR SPECTROPHOTOMETRIC ANALYSIS OF SIMULTANEOUS ESTIMATION OF BISOPROLOL FUMARATE TABLET FORMULATIONS USING HYDROTROPY SOLUBILIZATION AGENTS

    2010

    7 cites
  96. Formulation and Development of Posaconazole Loaded Controlled Release Nanosponge Topical Gel for the Treatment of Fungal Infection

    2025

    View DOI
    6 cites
  97. Laser empowered ‘chemo-free’ phytotherapy: Newer approach in anticancer therapeutics delivery

    Journal of Drug Delivery Science and Technology2022journal article

    View DOI
    6 cites
  98. Understanding the concept of signal toxicity and its implications on human health

    2022

    View DOI
    6 cites
  99. New emerging technologies for genetic toxicity testing

    2022

    View DOI
    6 cites
  100. Emerging role of novel excipients in drug product development and their safety concerns

    2022

    View DOI
    6 cites
  101. Biopharmaceutical considerations in the pediatric and geriatric formulation development

    2021

    View DOI
    6 cites
  102. Molecular modeling studies on substituted aminopyrimidines derivatives as potential antimalarial compounds

    2014

    View DOI
    6 cites
  103. Syntheses and X-ray crystal structures of five- and six-coordinate copper(II) complexes of <i>N</i>,<i>N</i>,<i>N</i>′,<i>N</i>′-tetraalkylpyridine-2,6-dicarboxamides containing–OClO<sub>3</sub> and–OSO<sub>2</sub>CF<sub>3</sub> counter ions

    2010

    View DOI
    6 cites
  104. Variation among commercial cultivars of Japanese mint (<i>Mentha arvensis</i>L.) in the morphological and metabolite characters associated with essential oil yield

    2003

    View DOI
    6 cites
  105. Synthesis and Crystal Structures of Mixed Halophenylbismuthates(III)

    2000

    View DOI
    6 cites
  106. Research on Alzheimer's Disease (AD) Involving the Use of In vivo and In vitro Models and Mechanisms

    Central Nervous System Agents in Medicinal Chemistry2025journal article

    View DOI
    5 cites
  107. Principles and concepts in toxicokinetic

    2022

    View DOI
    5 cites
  108. Nanotechnology in Tissue Engineering

    2019

    View DOI
    5 cites
  109. Computational study of diarylcyclopentene derivatives as selective prostaglandin EP1 receptor antagonist: QSAR approach

    2016

    View DOI
    5 cites
  110. RP-HPLC-PDAAnalyses of Tapentadol: Application of Experimental Design

    Analytical Chemistry Letters2016journal article

    View DOI
    5 cites
  111. Computational design of novel renin inhibitors of indole-3-carboxamide derivatives through QSAR studies

    2016

    View DOI
    5 cites
  112. Structural Requirements of Some 2-(1-Propylpiperidin-4-yl)-1H-benzimidazole-4-carboxamide Derivatives as Poly (ADP-Ribose) Polymerase (PARP) for the Treatment of Cancer: QSAR Approach

    2015

    View DOI
    5 cites
  113. A comparative QSAR analysis of substituted imidazolones derivatives as angiotensin II AT1 receptor antagonists

    2015

    View DOI
    5 cites
  114. Prospective QSAR-Based Prediction Models with Pharmacophore Studies of Oxadiazole-Substituted $$\alpha$$ α -Isopropoxy Phenylpropanoic Acids with Dual Activators of PPAR $$\alpha$$ α and PPAR $$\gamma$$ γ

    2015

    View DOI
    5 cites
  115. A Structure–Activity Relationship Study of Naphthoquinone Derivatives as Antitubercular Agents Using Molecular Modeling Techniques

    2015

    View DOI
    5 cites
  116. Synthesis and Biological Evaluation of Potent Antihypertensive Activity: 2-[(Substituted-phenyl amino)-phenyl-methyl]-1-[2'-(1H-tetrazol-5-yl) biphenyl-3-ylmethyl]-1H-benzoimidazol-5-ylamine Derivatives

    2010

    5 cites
  117. Phytochemical Screening and In vitro Antimicrobial Activity of Combined Citrus paradisi and Ficus carica Linn Aqueous Extracts

    2010

    5 cites
  118. Investigation on Quantitative Structure Activity Relationships of a Series of Inducible Nitric Oxide

    Interdisciplinary Sciences: Computational Life Sciences1970journal article

    View DOI
    5 cites
  119. Recent Advances in the Synthesis of Antioxidant Derivatives: Pharmacological Insights for Neurological Disorders

    2024

    View DOI
    4 cites
  120. Novel applications of Cold Atmospheric Plasma for the treatment of Plaque Psoriasis

    2023

    View DOI
    4 cites
  121. Impact of ageing on the pharmacokinetics and pharmacodynamics of the drugs

    2022

    View DOI
    4 cites
  122. DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF CLIDINIUM BROMIDE, CHLORDIAZEPOXIDE AND DICYCLOMINE HYDROCHLORIDE IN TABLET DOSAGE FORM

    2021

    View DOI
    4 cites
  123. Murder Mystery Solved with the Help of Forensic Investigation

    2020

    View DOI
    4 cites
  124. Recent advancements in solubilization of hydrophobic drugs

    2020

    View DOI
    4 cites
  125. Exploration of important sites of angiotensin II AT1 receptor of Pyrido [2, 3-d] pyrimidine analogues for structural modification using computational approach

    2016

    View DOI
    4 cites
  126. Rationalization of physicochemical characters and structural determinants of benzimidazole analogues as casein kinase 2 inhibitors: computational approach

    2016

    View DOI
    4 cites
  127. Predictive QSAR modeling of substituted Phenylpyrazinones as corticotropin-releasing factor-1 (CRF1) receptor antagonists: computational approach

    2015

    View DOI
    4 cites
  128. Discovery of Potent Antihypertensive Ligands Substituted Imidazolyl Biphenyl Sulfonylureas Analogs as Angiotensin II $$\hbox {AT}_{1}$$ AT 1 Receptor Antagonists by Molecular Modelling Studies

    2015

    View DOI
    4 cites
  129. QSAR studies on 3-(4-biphenylmethyl) 4, 5-dihydro-4-oxo-3H-imidazo [4, 5-c] Pyridine derivatives as angiotensin II (AT1) receptor antagonist

    2015

    View DOI
    4 cites
  130. Prediction of potent therapeutic anticonvulsant ligands to<i>N</i>-methyl-<scp>d</scp>-aspartate receptors among substituted 4,6-dichloroindole-2-carboxylic acids: Molecular modeling approach

    2013

    View DOI
    4 cites
  131. Qsar study of some substituted 4-quinolinyl and 9-acridinyl hydrazones as antimalarial agents.

    2013

    4 cites
  132. Extractive Spectrophotometric Methods for the Determination of Emtricitabine in Dosage Form Using Safranin O

    2011

    4 cites
  133. Some plant extracts used in pharmacologically activity of anxiolytics, antidepressant, analgesic, and anti-inflammatory activity

    2010

    View DOI
    4 cites
  134. NEW SPECTROPHOTOMETRIC METHODS FOR ESTIMATION OF ANASTRAZOLE BULK AND TABLET DOSAGE FORM BY DERIVATIVE SPECTROSCOPY

    2010

    4 cites
  135. IN VITRO MICROPROPAGATION OF MEDICINALLY IMPORTANT ROOTS AND AXILLARY BUD COMBINATION

    2009

    4 cites
  136. Potential estimation of [the] predatory bug, Canthecona furcellata Wolff (Hemiptera: Pentatomidae) against [the] poplar defoliator, Clostera cupreata (Lepidoptera: Notodontidae).

    1996

    4 cites
  137. Synthesis and biological evaluation of some substituted benzimidazole derivatives as antihypertensive activities

    2023

    View DOI
    3 cites
  138. Clinical detoxification of the body from chemical toxicants

    2023

    View DOI
    3 cites
  139. Zebrafish models for toxicological screening

    2022

    View DOI
    3 cites
  140. SIMULTANEOUS DETERMINATION OF PARACETAMOL, ACECLOFENAC AND TRAMADOL HYDROCHLORIDE IN PHARMACEUTICAL DOSAGE FORM BY RP-HPLC METHOD

    2021

    View DOI
    3 cites
  141. 3D printing as an emerging tool in pharmaceutical product development

    2020

    View DOI
    3 cites
  142. Approaches to the Development of Implantable Therapeutic Systems

    2019

    View DOI
    3 cites
  143. In silico screening for identification of pyrrolidine derivatives dipeptidyl peptidase-IV inhibitors using COMFA, CoMSIA, HQSAR and docking studies

    2017

    View DOI
    3 cites
  144. QSAR APPROACH TO THE STUDY OF THE EGFR TYROSINE KINASE INHIBITORS: THIAZOLYL-PYRAZOLINE DERIVATIVES

    2017

    View DOI
    3 cites
  145. QSAR STUDIES ON PYRAZOLO [1, 5-A] PYRIMIDINE-BASED PIM-1 KINASE INHIBITORS

    2016

    View DOI
    3 cites
  146. STRUCTURAL FEATURE STUDY OF FUROXAN DERIVATIVES AS POTENT ANTI-TRYPANOSOMATID AGENTS: QSAR APPROACH

    2016

    View DOI
    3 cites
  147. OPTIMIZATION OF ANTIPROLIFERATIVE ACTIVITY OF SYNTHETIC UREDIO-SUBSTITUTED SULFAMATE DERIVATIVES: QSAR APPROACH

    2016

    View DOI
    3 cites
  148. X-Ray Fluorescence Analysis: Useful For Forensic Examination

    2016

    View DOI
    3 cites
  149. Molecular Modeling Studies of Some Substituted 2-Phenyl-benzimidazole Derivatives as Inhibitors of IgE Response

    2015

    View DOI
    3 cites
  150. Comparative pharmacophore modeling and QSAR studies for structural requirements of some substituted 2-aminopyridines derivatives as inhibitors nitric oxide synthases

    2014

    View DOI
    3 cites
  151. SIMULTANEOUS DETERMINATION OF OFLOXACIN AND CEFIXIME IN COMBINED TABLET DOSAGE FORM BY HPLC AND ABSORBANCE CORRECTION METHOD

    2014

    3 cites
  152. WITHDRAWN: Molecular modeling and pharmacophore approach substituted benzimidazole derivatives as dipeptidyl peptidase IV inhibitors

    2013

    View DOI
    3 cites
  153. Design; Synthesis and Antihypertensive activity of 4'-(2-{2-[(2-chloro-benzylidene)-amino]-phenyl}-5-nitro-benzoimidazol-1-ylmethyl)] biphenyl-2-carboxylic acid

    2010

    View DOI
    3 cites
  154. Molecular Modelling Studies atom based of 3-Bromo-4-(1-H-3-Indolyl)-2, 5-Dihydro-1H-2, 5-Pyrroledione Derivatives Antibacterial activity against Staphylococcus Aureus

    2010

    3 cites
  155. Phytochemical and anti-ulcer investigations of 95% ethanolicbenzene-chloroform leaf extract of Hibiscus tiliaceus Linn. in albino rat model

    2010

    3 cites
  156. Pharmacognostic and phytochemical screening of Vernonia amyggalina Linn against selected bacterial strains.

    2010

    3 cites
  157. Additions to the flora of Himachal Pradesh from Kulu district

    1997

    View DOI
    3 cites
  158. Clinical Evidence of Traditional Medicines in Modulating the Immune Response and Diabetic Wound Healing

    2025

    View DOI
    2 cites
  159. THE EVOLVING ROLE OF PHYTOCHEMICALS IN CANCER THERAPY: MECHANISTIC INSIGHTS AND EMERGING TECHNOLOGIES

    2025

    View DOI
    2 cites
  160. Advances in Molecular Docking Techniques for Targeting Protein Misfolding in Neurodegenerative Diseases

    2025

    View DOI
    2 cites
  161. Molecular Mechanisms and Pathways of Mesenchymal Stem Cell-mediated Therapy in Brain Cancer

    2025

    View DOI
    2 cites
  162. Immune Modulation Strategies in Gene Therapy: Overcoming Immune Barriers and Enhancing Efficacy

    2024

    View DOI
    2 cites
  163. Herbal Antibiotics: A Review of Traditional Medicinal Plants with Antibacterial Properties and Their Potential for Future Treatment

    2024

    View DOI
    2 cites
  164. Effect of supported sitting position during second stage of labor on its outcome in primigravidae: A quasi-experimental study

    2023

    View DOI
    2 cites
  165. A pilot study on review of GSR with a case study

    2022

    View DOI
    2 cites
  166. Clinical importance of herb–drug interaction

    2022

    View DOI
    2 cites
  167. Pharmacokinetics and biopharmaceutics: “a leader or attendant”

    2021

    View DOI
    2 cites
  168. Synthesis and Evaluation of Phenol Derivatives of Sulfonyl Chloride Quinoxaline

    2019

    View DOI
    2 cites
  169. DEVELOPMENT OF A ROBUST QSAR MODEL OF ANGIOTENSIN RECEPTOR REVEALS A K NEAREST NEIGHBOR APPLICABLE TO DIVERSE SCAFFOLDS

    2017

    View DOI
    2 cites
  170. Molecular modeling study of uracil-based hydroxamic acids-containing histone deacetylase inhibitors

    2015

    View DOI
    2 cites
  171. Discovery of potent antihypertensive ligands substituted imidazolyl biphenyl sulfonylureas analogs as angiotensin II AT1 receptor antagonists by molecular modelling studies

    2014

    View DOI
    2 cites
  172. Prospective QSAR-based prediction models with pharmacophore studies of oxadiazole-substituted α-isopropoxy phenylpropanoic acids on with dual activators of PPARα and PPARγ

    2014

    View DOI
    2 cites
  173. A structure-activity relationship study of imidazole-5-carboxylic acids derivatives as angiotensin II receptor antagonists combining 2D and 3D QSAR methods

    2014

    View DOI
    2 cites
  174. Identification of 3-nitro-2, 4, 6-trihydroxybenzamide derivatives as photosynthetic electron transport inhibitors by QSAR and pharmacophore studies

    2014

    View DOI
    2 cites
  175. Structural insights into mode of actions of novel substituted 4- and 6-azaindole-3-carboxamides analogs as renin inhibitors: molecular modeling studies

    2014

    View DOI
    2 cites
  176. Validated Densitometric Method for the Quantification of Mesalamine in Pharmaceutical Dosage form

    2013

    View DOI
    2 cites
  177. UV-Visible spectrophotometry of Repaglinide in bulk and in formulation by using methyl orange as reagents

    2011

    2 cites
  178. Sensitive and spectrophotometric methods for the determination of Azathioprine in tablets using indigo carmine and methyl orange

    2011

    2 cites
  179. Application of hydrotropic solubilization in spectrophotometric analysis of Esomeprazole and Itopride pharmaceutical combined tablet dosage forms

    2011

    2 cites
  180. Formulation and evaluation of analgesic activity, anti-inflammatory and anti-anxiety activity of using plant extracts

    2010

    View DOI
    2 cites
  181. Formulation and antimicrobial activity of 95% ethanolic-benzenechloroform extract of Curcuma aromatica Salisb

    2010

    2 cites
  182. Reductive cleavage with metal in liquid ammonia. III. Olefin formation from the reaction of sodium metal with methyl 4,6-<i>O</i>-ethylidene-3-<i>O</i>,<i>S</i>-dimethyl-2-thio-α-<scp>d</scp>-altropyranoside dissolved in 1,2-dimethoxyethane

    1967

    View DOI
    2 cites
  183. Emerging Applications and Innovations in Emulgel Technology for Enhanced Topical Drug Delivery

    2025

    View DOI
    1 cites
  184. An Updated Review on the Complex Association of Cardiovascular Disease (CVD) and Depression

    2025

    View DOI
    1 cites
  185. Soil: forensic interpretation some cases study

    2024

    View DOI
    1 cites
  186. Pharmacophore and k nearest neighbor studies on pyridazinylmethyl glucoside congeners derivative as potential antidiabetic agents

    2023

    View DOI
    1 cites
  187. Quantitative structure activity relationship studies of some quinoline derivatives of angiotensin II receptor inhibitors

    2023

    View DOI
    1 cites
  188. Preformulation and synthesis of retinol acetate nanoemulsion for skin disorder

    2023

    View DOI
    1 cites
  189. Antipsoriatic activity of imiquimod induced wistar model treated with cholecalciferol nanoemulsion with UV therapy

    2023

    View DOI
    1 cites
  190. Analysis of Soil in Crime Cases and Its Importance: Cases Study

    2023

    View DOI
    1 cites
  191. Molecular biology of apoptotic, necrotic, and necroptotic cell death

    2022

    View DOI
    1 cites
  192. Toxicogenomics in drug safety assessment

    2022

    View DOI
    1 cites
  193. Organ-on-chip for assessing environmental toxicants

    2022

    View DOI
    1 cites
  194. Influence of fever on pharmacokinetics of drugs

    2021

    View DOI
    1 cites
  195. Antimicrobial and Antifungal Activity of newly synthesized 4-Hydroxy Quinoline Derivatives

    2020

    1 cites
  196. Resealed erythrocytes (RBCs) and their biomedical application

    2020

    View DOI
    1 cites
  197. Recombinant blood products and therapeutic enzymes: An update

    2020

    View DOI
    1 cites
  198. Up-to-Date Implications of Nanomaterials in Dental Science

    2019

    View DOI
    1 cites
  199. Exploration of new scaffolds pyrazole derivatives containing thiourea skeleton as anticancer activity using QSAR approach

    2017

    View DOI
    1 cites
  200. Predictive Activity Modeling of 2-Substituent-1H-Benzimidazole-4- Carboxamide Derivatives against Enteroviruses using QSAR Approach

    2015

    View DOI
    1 cites
  201. QSAR Studies of 3, 4-dihydropyrimidin-2(1H)-one Urea Derivatives as Antibacterial and Antifungal activity

    2015

    View DOI
    1 cites
  202. Structural requirements of some 2-(1-propylpiperidin-4-yl)-1H-benzimidazole-4-carboxamide derivatives as poly (ADP-ribose) polymerase (PARP) for the treatment of cancer: QSAR approach

    2014

    View DOI
    1 cites
  203. Densitometric Method for the Quantification of Melitracen hydrochloride and Flupentixol dihydrochloride in Pharmaceutical Dosage Form

    2014

    View DOI
    1 cites
  204. Forensic Study of Indian Toxicological Plants as Botanical Weapon (BW)

    2011

    1 cites
  205. WOUND HEALING ACTIVITY OF THE ETHER-CHLOROFORM EXTRACT OF MOMORDICA CHARANTIA FRUITS S IN RATS

    2010

    1 cites
  206. QSAR and k-Nearest Neighbour Molecular Field Analysis (k-NN MFA) Classification Analysis of Studies of Some Bemzimidazoles Derivatives Antibacterial activity Against Escherichia coli

    2010

    1 cites
  207. Conventional and Micellar Liquid Chromatography Method with Validation for Torsemide and Spironolactone in Tablet CombinedDosage Form

    2010

    1 cites
  208. Studies of antibacterial activity ethernolic plant extract of Mollugo pentaphylla Linn

    2010

    1 cites
  209. 0 cites
  210. Pharmacological Activity of Scopoletin: Deciphering the Potential of Coumarins in Cognitive Dysfunction

    2025

    View DOI
    0 cites
  211. Advancements in Precision Oncology: Harnessing High-Throughput Screening and Computational Strategies for Targeted Cancer Therapies

    2025

    View DOI
    0 cites
  212. Exploring the Dual Roles of Neural Stem Cells in Glioblastoma: Therapeutic Implications and Opportunities

    2025

    View DOI
    0 cites
  213. Emulgel-Based Formulations of Clobetasol Propionate: Formulation Development, Characterization, and Pharmacological Evaluation

    2025

    View DOI
    0 cites
  214. The Intersection of Bioethics, Law, and Surgical Procedures

    2025

    View DOI
    0 cites
  215. 0 cites
  216. AI in Clinical Trials and Drug Development: Challenges and Potential Advancements

    Current Drug Discovery Technologies2024journal article

    View DOI
    0 cites
  217. Biomarkers and Novel Therapies of Diabetic Neuropathy: An Updated Review

    Current Pharmaceutical Biotechnology2024journal article

    View DOI
    0 cites
  218. Endometriosis: A Comprehensive and Concise Review of Potential Biomarkers and Treatment Therapies

    2024

    View DOI
    0 cites
  219. Exploring the impact of a structured teaching programme among neonatal nurses in the prevention and management of Retinopathy of Prematurity (ROP): A pre-experimentals study at a tertiary hospital

    2024

    View DOI
    0 cites
  220. Pandemic and Pregnancy: A Systematic Review on the Effect of the COVID-19 Drugs on Pregnant Women’s

    2024

    View DOI
    0 cites
  221. HEART HOLE- AN ABNORMAL BIRTH DEFECT

    2023

    View DOI
    0 cites
  222. Potential of Azadirachta indica A. Juss., Eucalyptus globulus Labill. and Ocimum sanctum L. Phytochemicals as Herbal Hand Sanitizer: A Review

    2023

    View DOI
    0 cites
  223. Exploring the molecular structural requirements of 3, 4, 5-trisubstituted triazoles and imidazotriazole analogues as angiotensin II receptor using molecular modeling approach

    2023

    View DOI
    0 cites
  224. 32 Factorial Design of O/W Nanoemulsions of Cholecalciferol Using Box–Behnken Model for Plaque Psoriasis

    Indian Journal of Pharmaceutical Education and Research2023journal article

    View DOI
    0 cites
  225. A Novel Approaches to Feverfew (&lt;i&gt;Tanacetum Prthenium&lt;/i&gt;): A Review

    2023

    View DOI
    0 cites
  226. Houttuynia cordata Thumb. extract for the treatment of triple negative breast cancer

    2023

    View DOI
    0 cites
  227. Synthesis and biological evaluation of some substituted pyrazolopyrimidines derivatives as potential a-glucosidase inhibitors

    2023

    View DOI
    0 cites
  228. List of contributors

    2023

    View DOI
    0 cites
  229. 0 cites
  230. 2D QSAR STUDIES OF NOVEL TRIAZOLINONE DERIVATIVES AS ANGIOTENSIN II ANTAGONISTS USING TOPOLOGICAL DESCRIPTORS

    2022

    View DOI
    0 cites
  231. STRUCTURAL FEATURE STUDY OF QUINOLINES DERIVATIVES WITH THERMODYNAMIC AND OTHER DESCRIPTORS: A QSAR APPROACH

    2021

    View DOI
    0 cites
  232. Synthesis, Characterization and Anti-Microbial Activity of Some Hydrazone Derivatives

    2021

    0 cites
  233. List of contributors

    2021

    View DOI
    0 cites
  234. Design, synthesis, and pharmacological evaluation of 4'-{2-[4-[3- chloro-2-(substituted-phenyl)-4-oxo-azetidin-1-yl)-phenyl]- benzoimidazol-1-ylmethyl}-biphenyl-2-carboxylic acids

    2021

    0 cites
  235. Fifatrol, An Ayurvedic Formulation-A Prospective Multi-Center Observational Study On The Symptoms of Upper Respiratory Tract Infections

    2021

    View DOI
    0 cites
  236. STRUCTURAL REQUIREMENTS OF SOME TRIAZOLONE DERIVATIVES USING TOPOLOGICAL AND PHYSICOCHEMICAL DESCRIPTORS: QSAR APPROACH

    2020

    View DOI
    0 cites
  237. THREE-DIMENSIONAL QSAR MODELING BENZIMIDAZOLE ANALOGUES USING THE K-NEAREST NEIGHBOR METHOD

    2019

    View DOI
    0 cites
  238. Role of Clay-Gel Hybrids in Enhancing Carbon Sequestration

    2019

    0 cites
  239. Synthesis and Evaluation of Aldehyde Derivatives of Sulfonyl Chloride Quinoxaline

    2019

    View DOI
    0 cites
  240. Anisotropic thermoelectric properties of EuCd$_{2}$As$_{2}$ : An Ab-initio study

    2019

    View DOI
    0 cites
  241. Design and prediction of favorable substitution site in trifluorophenyl-substituted homopiperazine, pyrazoline, triazepane derivatives as dipeptidyl peptidase IV Inhibitors: HQSAR and docking studies

    2019

    View DOI
    0 cites
  242. INSIGHT INTO THE STRUCTURAL REQUIREMENTS OF SULFONYL DERIVATIVES BASED ON TWO AND THREE-DIMENSIONAL DESCRIPTORS: QSAR STUDIES

    2019

    View DOI
    0 cites
  243. List of Contributors

    2019

    View DOI
    0 cites
  244. DEVELOPMENT OF A CREDIBLE QSAR AND K NEAREST NEIGHBOR MODELS FOR IMIDAZOLYL DERIVATIVES

    2018

    View DOI
    0 cites
  245. Probing the structural requirements for angiotensin II receptor: molecular modeling studies

    2018

    View DOI
    0 cites
  246. CRYSTAL STRUCTURE OF PfKRS WITH INHIBITOR CLADO-5

    2018

    View DOI
    0 cites
  247. CRYSTAL STRUCTURE OF PfKRS WITH INHIBITOR CLADO-2

    2018

    View DOI
    0 cites
  248. PREDICTING POTENT ANTIHYPERTENSIVE COMPOUNDS OF PYRIDINE DERIVATIVES BY MOLECULAR MODELING APPROACH

    2018

    View DOI
    0 cites
  249. Unit-9 Atomic Structure, Periodic Classification and Chemical Bonding

    2018

    0 cites
  250. QUANTITATIVE STRUCTURE - ACTIVITY RELATIONSHIP STUDIES OF SOME BENZIMIDAZOLE ANALOGUES BASING ON PARTIAL LEAST SQUARES METHOD

    2017

    View DOI
    0 cites
  251. QUANTITATIVE STRUCTURE ACTIVITY RELATIONSHIP MODELING FOR PREDICTION OF PYRIDINE SUBSTITUTED ANALOGUES WITH K-NEAREST NEIGHBOR STUDIES

    2017

    View DOI
    0 cites
  252. Prediction of structural requirements of AT1 receptor through application of pharmacophore-based 3D-QSAR studies

    2017

    View DOI
    0 cites
  253. PREDICTIVE QSAR MODELING OF PYRIDAZINYL DERIVATIVES USING K-NEAREST NEIGHBOR AND PHARMACOPHORE APPROACH

    2017

    View DOI
    0 cites
  254. Detection of Biofilms in <i>Candida</i> Species in a Resource Limited Setting

    2017

    View DOI
    0 cites
  255. QSAR Analysis of 3- and 4-substituted 7-hydroxycoumarins as Novel 17?-HSD3 Inhibitors

    2015

    View DOI
    0 cites
  256. Theoretical Studies of Substituted N-(1H Benzimidazol-2ylmethyl)-5,6,7,8-Tetrahydro-8-Quinolinamines as CXCR4 Antagonists: QSAR Approach

    2015

    View DOI
    0 cites
  257. 2D QSAR Studies on a Series of Benzimidazole Type of Fluconazole Analogues as Antimicrobial Agents

    2015

    View DOI
    0 cites
  258. Rational Drug Design of Substituted Analogues Angiotensin II Receptor

    2014

    0 cites
  259. Development and Validation of Anti-Tussive Drugs in Dosage Form

    2014

    0 cites
  260. Research Article Physico-Chemical and Phyto-Chemical Study of Rhizome of Dryopteris cochleata

    2014

    0 cites
  261. CCDC 825045: Experimental Crystal Structure Determination

    2013

    View DOI
    0 cites
  262. Simultaneous Estimation and Validation of Alfuzosin hydrochloride in Pharmaceutical Dosage Form by Hydrotropic Solubilization Phenomenon

    2013

    View DOI
    0 cites
  263. Simultaneous Estimation and Validation of Mefenamic Acid and Drotaverine Hydrochloride in Tablet Dosage Form.

    2013

    View DOI
    0 cites
  264. CCDC 813149: Experimental Crystal Structure Determination

    2012

    View DOI
    0 cites
  265. Studies on metal complexes of N N N N tetraalkyl arylpyridine 2 6 dicarboxamide and dialkyl arylpyridine 2 6 dicarboxylate ligands

    2011

    0 cites
  266. THREE-DIMENSIONAL QUANTITATIVE STRUCTURE ACTIVITY RELATIONSHIP APPROACH SERIES OF 3-BROMO-4-(1-H-3 INDOLYL)-2, 5-DIHYDRO-1H-2, 5-PYRROLEDIONE AS ANTIBACTERIAL AGENTS

    2010

    0 cites
  267. Phytochemical and anti-ulcer investigations of 95% ethanolicbenzene-chloroform leaf extract of Hibiscus tiliaceus Linn. inalbino rat model

    2010

    0 cites
  268. SIMULTANEOUS SPECTROPHOTOMETRIC ESTIMATION OF ETOPOSIDETABLET FORMULATIONS USING HYDROTROPY SOLUBILIZATION AGENTS

    2010

    0 cites
  269. WOUND HEALING ACTIVITY OF THE ETHER-CHLOROFORM BENZENE- 95% EXTRACT OF MOMORDICA CHARANTIA FRUITS S IN ALBINO RATS

    2009

    0 cites
  270. CCDC 652339: Experimental Crystal Structure Determination

    2008

    View DOI
    0 cites
  271. CCDC 171426: Experimental Crystal Structure Determination

    2002

    View DOI
    0 cites
  272. CCDC 149361: Experimental Crystal Structure Determination

    2001

    View DOI
    0 cites
  273. CCDC 149360: Experimental Crystal Structure Determination

    2001

    View DOI
    0 cites
  274. Quantitative relationship of diamagnetic susceptibility with molecular connectivity in hydrocarbons

    1993

    0 cites
  275. 2D-QSAR STUDIES OF SOME 1, 3, 4-THIDIAZOLE-2YL AZETIDINE 2-ONE AS ANTIMICROBIAL ACTIVITY

    Digest Journal of Nanomaterials and Biostructures1970journal article

    0 cites